Maravai LifeSciences/$MRVI
13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1Y5YMAX
About Maravai LifeSciences
Maravai LifeSciences Holdings Inc is a life sciences company providing products and services to enable the development of drugs, therapeutics, vaccines and diagnostics, and to support research on human disease. Its product portfolio includes complex nucleic acids, custom enzymes and antibody-based solutions for therapeutic, vaccine, diagnostic and biopharmaceutical production applications. The Company operates through two segments: TriLink, which generates maximum revenue from North America and provides nucleic acid products and services including mRNA, oligonucleotides and related technologies; and Cygnus, which provides biologics safety testing products and services including host cell protein ELISA kits, impurity detection assays and related reagents and services.
Ticker
$MRVI
Sector
Primary listing
Employees
435
Headquarters
Website
MRVI Metrics
BasicAdvanced
$512M
-
-$0.91
0.35
-
Price and volume
Market cap
$512M
Beta
0.35
52-week high
$4.11
52-week low
$1.67
Average daily volume
1.2M
Financial strength
Current ratio
6.596
Quick ratio
5.396
Long term debt to equity
94.043
Total debt to equity
97.853
Interest coverage (TTM)
-4.70%
Profitability
EBITDA (TTM)
-74.121
Gross margin (TTM)
19.21%
Net profit margin (TTM)
-70.41%
Operating margin (TTM)
-67.64%
Effective tax rate (TTM)
1.79%
Revenue per employee (TTM)
$430,000
Management effectiveness
Return on assets (TTM)
-8.83%
Return on equity (TTM)
-45.74%
Valuation
Price to revenue (TTM)
2.72
Price to book
2.39
Price to tangible book (TTM)
-7.42
Price to free cash flow (TTM)
-7.144
Free cash flow yield (TTM)
-14.00%
Free cash flow per share (TTM)
-0.49
Growth
Revenue change (TTM)
-28.34%
Earnings per share change (TTM)
-13.75%
3-year revenue growth (CAGR)
-40.53%
3-year earnings per share growth (CAGR)
-18.44%
What the Analysts think about MRVI
Analyst ratings (Buy, Hold, Sell) for Maravai LifeSciences stock.
MRVI Financial Performance
Revenues and expenses
MRVI Earnings Performance
Company profitability
MRVI News
AllArticlesVideos
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
Capital at risk
Upcoming events
No upcoming events
FAQs
What’s the current market cap for Maravai LifeSciences stock?
Maravai LifeSciences (MRVI) has a market cap of $512M as of March 11, 2026.
What is the P/E ratio for Maravai LifeSciences stock?
The price to earnings (P/E) ratio for Maravai LifeSciences (MRVI) stock is 0 as of March 11, 2026.
Does Maravai LifeSciences stock pay dividends?
No, Maravai LifeSciences (MRVI) stock does not pay dividends to its shareholders as of March 11, 2026.
When is the next Maravai LifeSciences dividend payment date?
Maravai LifeSciences (MRVI) stock does not pay dividends to its shareholders.
What is the beta indicator for Maravai LifeSciences?
Maravai LifeSciences (MRVI) has a beta rating of 0.35. This means that it is less volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 0.5 would mean it moves half as much as the market.